[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks?

Viatris Inc. (VTRS) is a global healthcare powerhouse dedicated to expanding access to high-quality medicines and helping people live healthier lives at every stage. Leveraging a diverse portfolio that spans generics, established brands, and innovative therapies, the company addresses a wide range of healthcare needs, including areas with significant unmet demand. Backed by a global footprint, Viatris combines scale, innovation, and supply-chain resilience to deliver sustainable healthcare solutions to patients worldwide.

With a market value of roughly $17.89 billion, Viatris comfortably qualifies as a large-cap stock. Its sizable valuation not only exceeds the $10 billion benchmark for large-cap companies but...

Fundamentals

See More
  • Market Capitalization, $K 1,808,000
  • Shares Outstanding, K 22,745
  • Annual Sales, $ 883,370 K
  • Annual Income, $ 78,340 K
  • EBIT $ 213 M
  • EBITDA $ 305 M
  • 60-Month Beta 0.44
  • Price/Sales 2.07
  • Price/Cash Flow 8.11
  • Price/Book 3.28

Options Overview Details

View History
  • Implied Volatility 45.49% (+3.47%)
  • Historical Volatility 31.23%
  • IV Percentile 49%
  • IV Rank 31.59%
  • IV High 73.85% on 07/24/25
  • IV Low 32.40% on 09/22/25
  • Expected Move (DTE 27) 3.61 (4.54%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 25
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 8.65
  • Today's Open Interest 2,528
  • Open Int (30-Day) 2,492
  • Expected Range 75.88 to 83.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.67
  • Number of Estimates 3
  • High Estimate $1.69
  • Low Estimate $1.64
  • Prior Year $1.38
  • Growth Rate Est. (year over year) +21.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.54 +8.09%
on 06/03/26
83.96 -5.33%
on 06/10/26
+0.15 (+0.19%)
since 05/18/26
3-Month
72.60 +9.49%
on 03/27/26
87.76 -9.42%
on 05/08/26
+5.32 (+7.17%)
since 03/18/26
52-Week
62.60 +26.97%
on 07/31/25
99.50 -20.11%
on 09/10/25
+14.83 (+22.94%)
since 06/18/25

Most Recent Stories

More News
How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks?

Viatris has outperformed its industry peers over the past year, and Wall Street appears optimistic about the stock.

XLV : 149.40 (-0.87%)
VTRS : 15.37 (-2.29%)
ANIP : 79.49 (-1.28%)
2 Cash-Producing Stocks to Research Further and 1 Facing Challenges

2 Cash-Producing Stocks to Research Further and 1 Facing Challenges

CSGP : 30.12 (-1.12%)
TRU : 64.60 (+0.25%)
ANIP : 79.49 (-1.28%)
2 Growth Stocks with Explosive Upside and 1 We Avoid

2 Growth Stocks with Explosive Upside and 1 We Avoid

AMSC : 43.40 (+8.15%)
VRNS : 33.38 (+0.91%)
ANIP : 79.49 (-1.28%)
ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

PRINCETON, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside...

ANIP : 79.49 (-1.28%)
Q1 Earnings Outperformers: ANI Pharmaceuticals (NASDAQ:ANIP) And The Rest Of The Pharmaceuticals Stocks

Q1 Earnings Outperformers: ANI Pharmaceuticals (NASDAQ:ANIP) And The Rest Of The Pharmaceuticals Stocks

ANIP : 79.49 (-1.28%)
2 Profitable Stocks with Competitive Advantages and 1 Facing Headwinds

2 Profitable Stocks with Competitive Advantages and 1 Facing Headwinds

MYRG : 461.10 (+3.76%)
ANIP : 79.49 (-1.28%)
BGS : 3.89 (-0.26%)
ANI Pharmaceuticals Q1 Earnings Call Highlights

ANI Pharmaceuticals (NASDAQ:ANIP) reported first-quarter 2026 results that management said show continued progress in its effort to “accelerat[e] our transformation into a leading rare disease company,”...

ANIP : 79.49 (-1.28%)
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q1 CY2026, Stock Soars

ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q1 CY2026, Stock Soars

ANIP : 79.49 (-1.28%)
ANI: Q1 Earnings Snapshot

ANI: Q1 Earnings Snapshot

ANIP : 79.49 (-1.28%)
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

Quarterly net revenues of $237.5 million, an increase of 20.5% year-over-year Purified Cortrophin ® Gel net revenues of $75.1 million, an increase of 42.1% year-over-year Quarterly...

ANIP : 79.49 (-1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone...

See More

Key Turning Points

3rd Resistance Point 83.49
2nd Resistance Point 82.25
1st Resistance Point 80.87
Last Price 79.49
1st Support Level 78.24
2nd Support Level 77.00
3rd Support Level 75.62

See More

52-Week High 99.50
Fibonacci 61.8% 85.41
Fibonacci 50% 81.05
Last Price 79.49
Fibonacci 38.2% 76.70
52-Week Low 62.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.